Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Pulmonary embolism consensus.

Archivos de cardiologia de Mexico·2026
Same journal

[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine].

Archivos de cardiologia de Mexico·2026
Same journal

Safety and efficacy of dual-axis rotational vs standard coronary angiography: meta-analysis.

Archivos de cardiologia de Mexico·2026
Same journal

Influence of socioeconomic status on ST-segment elevation myocardial infarction in Mexico.

Archivos de cardiologia de Mexico·2026
Same journal

Right-sided juxtaposition of the left atrial appendage with orifice origin in unhabitual location: case report.

Archivos de cardiologia de Mexico·2026
Same journal

Data-driven atherosclerotic plaque profiles from QAngio-CT associated with functional impairments assessed with PET-CT.

Archivos de cardiologia de Mexico·2026

Related Experiment Video

Updated: Jul 10, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

[Vasovagal syncope: from genetic to bedside].

J Antonio G González-Hermosillo1

  • 1Departamento de Electrocardiología, Instituto Nacional de Cardiología Ignacio Chávez", Tlalpan 14080, México, DF. aghermo@yahoo.com

Archivos De Cardiologia De Mexico
|November 1, 2007
PubMed
Summary

Genetic factors may influence vasovagal syncope. This study investigated families with vasovagal syncope and explored genetic links to beta1-adrenergic receptor gene variations.

Area of Science:

  • Cardiology
  • Human Genetics
  • Pharmacogenomics

Background:

  • Vasovagal syncope (VVS) is increasingly recognized to have a hereditary component.
  • The genetic underpinnings of VVS phenotypes remain largely uncharacterized.
  • The beta1-adrenergic receptor (ADRB1) is crucial for cardiac function and a potential candidate gene.

Purpose of the Study:

  • To investigate the familial aggregation of vasovagal syncope.
  • To explore the association between ADRB1 gene polymorphisms and VVS.
  • To elucidate the genetic basis of VVS.

Main Methods:

  • Family-based case studies were conducted.
  • Genetic analysis focused on identifying polymorphisms in the beta1-adrenergic receptor gene.
  • Prevalence of specific polymorphisms was assessed in affected individuals and controls.

More Related Videos

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

Related Experiment Videos

Last Updated: Jul 10, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

Main Results:

  • Several families exhibited multiple members affected by vasovagal syncope, suggesting heritability.
  • Preliminary genetic analyses identified potential associations between ADRB1 polymorphisms and VVS.
  • Further studies are needed to confirm these genetic links.

Conclusions:

  • Familial clustering of VVS supports a significant genetic contribution.
  • Beta1-adrenergic receptor gene variants may play a role in the susceptibility to vasovagal syncope.
  • Identifying genetic factors could lead to personalized risk assessment and treatment strategies for VVS.